MAPT and Cognitive impairment: Several research groups announced that the cutoff values of plasma Aβ1–42xT-Tau levels for discriminating amnesic mild cognitive impairment and AD patients from cognitively normal controls range from 382 to 455 pg2/mL235,42,49.